Tracking an FDA advisory panel’s meeting on J&J’s Covid-19 vaccine
Now it’s Johnson & Johnson’s turn.
A panel of outside experts is meeting Friday for a third time to consider whether the Food and Drug Administration ought to give an emergency use authorization for a Covid-19 vaccine, this one from J&J. And for a third time, STAT reporters will live-blog the advisory committee’s deliberations.
Read Original Article: Tracking an FDA advisory panel’s meeting on J&J’s Covid-19 vaccine »
